Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.
A number of recent price target changes have been made on Teladoc Health, including:
Piper Sandler raises target price...
Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC
SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared...
Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...
MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics...
Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.
Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner...
Telehealth: How the Pandemic Forced Mental Health Care to Change for the Better (Vox).
New therapy options were desperately needed before the pandemic
Two facts overshadow all discussions of mental health care...
Kevin Harrington Presentation. (Video)
The Three Strategies I've Used to Build Businesses.
https://youtu.be/aNZAAKxPNlM
Shark Tanks’ Kevin...
Dalrada (DFCO) Finally Pops. Up 59% Today.
Up 59% today on news and with 4 million shares trading and counting!
LIVE QUOTE
CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.
“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
CB Scientific (CBSC): News Archive
Recent Headlines
Continously Updated
April 8th, 2021. My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application,...
Hapbee’s (HAPB) Device, “Choose How You Feel.”
HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL'
Proprietary, Research-Backed...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
